Obstetrics & Gynecology Doctors in Haverhill, MA Accepting Medicare

10 Obstetrics & Gynecology doctors found. Showing 1 - 10

Dr. Christannah M Waters, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 62 Brown St, Suite 405, Haverhill, MA 01830 Phone: 978-912-7450    Fax: 978-912-7420

Jane Kerr-fernandez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Primrose St Ste 202, Haverhill, MA 01830 Phone: 978-556-1000    Fax: 978-556-0101

Steven Mollov, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Primrose St Ste 202, Haverhill, MA 01830 Phone: 978-556-1000    Fax: 978-556-0100

Ms. Mary C. Chang, D.O. Obstetrics & Gynecology - Obstetrics Medicare: Medicare Enrolled Practice Location: 600 Primrose St Ste 202, Haverhill, MA 01830 Phone: 978-556-1000    Fax: 978-556-0094

Dr. Melinda Ropar Birdsall, M.D. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 62 Brown Street Suite 202, Merrimack Valley Gynecology, Haverhill, MA 01830 Phone: 978-914-7736    Fax: 978-702-4432

Celeste Royce, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Water St, Central Plaza, Haverhill, MA 01830 Phone: 978-556-0100

Susan Newhouse, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2 Water St, Central Plaza, Haverhill, MA 01830 Phone: 978-556-0100

Mary Baker-berzansky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Water St, Central Plaza, Haverhill, MA 01830 Phone: 978-556-0100

Alda Andoni, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Primrose St Ste 202, Haverhill, MA 01830 Phone: 978-556-0100    Fax: 978-556-0101

Dr. Rebecca Lynn Boyer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Primrose St Ste 202, Haverhill, MA 01830 Phone: 978-556-0100    Fax: 978-556-0094

News Archive

Experts indicate new way via which tumor cells can respond to chemotherapy

An international group of researchers, with the participation of the members of the University of Seville and the Andalusian Centre of Molecular Biology and Regenerative Medicine has just published a study in the prestigious review Science, in which they describe a new methodology for making tumor cells behave when submitted to chemotherapy, which, in the hope of new treatments, continues to be a fundamental tool in the fight against cancer.

Study: Most pediatric cancer patients have mild COVID-19 and make full recovery

Most children and adolescents with cancer have mild COVID-19 disease and make a full recovery, a new study has found. But pediatric cancer patients with underlying health conditions, severe infections and low white blood cell counts were significantly more likely to have severe disease.

BioElectronics plans to move trading of common shares to OTCBB quotation system

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the organization is in the process of working with market makers to move the trading of its common shares to the OTCBB quotation system. This comes about as a result of the recent completion of full financial audits for the years 2005 through 2009 and the filing of Form 10K with the U.S. Securities and Exchange Commission. BioElectronics is now a fully reporting company.

TSRI scientists develop new methods to design precision medicines against disease-causing RNAs

Scientists on the Florida campus of The Scripps Research Institute have developed broad methods to design precision medicines against currently incurable diseases caused by RNA.

Researchers map unknown microorganisms in human intestinal flora

Researchers from DTU Systems Biology have mapped 500 previously unknown microorganisms in human intestinal flora as well as 800 also unknown bacterial viruses (also called bacteriophages) which attack intestinal bacteria.

Read more Medical News

› Verified 1 days ago